Company Filing History:
5 out of 1,744 
3 out of 280 
2 out of 5,089 
Years Active: 2011-2019
Title: The Innovative Contributions of Isabelle Teulon
Introduction
Isabelle Teulon is a prominent inventor based in Saint Gely du Fesc, France. She has made significant contributions to the field of immunology, particularly in the development of antibody formats and their applications. With a total of 5 patents to her name, her work has the potential to impact cancer treatment and diagnostics.
Latest Patents
One of her latest patents focuses on the production of antibody formats and immunological applications of said formats. This invention concerns antibody formats that comprise VH sequences of Camelidae, such as llamas. The antibodies of various formats have anti-CEA or anti-CD16 VH sequences, along with vectors expressing these antibody formats and methods for their production. Another notable patent involves monoclonal antibodies and fragments directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II). This invention relates to the use of these antibodies for treating and diagnosing cancer diseases, including ovarian cancers.
Career Highlights
Isabelle Teulon has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and the Université de Montpellier. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific advancements.
Collaborations
Throughout her career, Isabelle has collaborated with notable colleagues, including André Pelegrin and Daniel Baty. These partnerships have further enriched her research and innovation efforts.
Conclusion
Isabelle Teulon's work exemplifies the impact of innovative thinking in the field of immunology. Her patents and collaborations highlight her commitment to advancing medical science and improving treatment options for cancer patients.